New drug for Alzheimer's?RSS Feed

A new drug could be used to treat the brain injury seen in Alzheimer's disease, research has indicated.

Scientists from the University of California, San Diego, found that oral administration of a cysteine protease inhibitor, E64d, reduced the build up of beta amyloid in the brain and significantly improved memory deficit.

According to the research, published in the Journal of Alzheimer's disease, this indicates Cathepsin B as a new therapeutic target, which could potentially lead to new treatments for the condition.

Lead investigator Vivian Y H Hook commented: "The finding is especially exciting because E64d has previously been shown safe for use in humans, so we believe the compound has strong potential as a new therapy for Alzheimer's disease."

This follows a breakthrough in Alzheimer's research which saw scientists narrowing in on the novel location within the MS4A gene cluster which is associated with the condition, according to the study published in journal Genome Medicine.

News by Serious Law. Expert legal assistance for those affected by brain injury

Posted by Timothy Walters
 

Gene detects treatment response of brain cancer patients

01 June 2011

A gene has been identified which is able to detect which patients with a certain type of brain cancer will respond better to treatment, potentially bringing hope to those with the brain injury.Ohio State...

Read More...

New treatment 'dissolves' blood clots in brain

31 May 2011

A new treatment could be used to dissolve blot clots in the brain, potentially lessening the brain injury caused by the condition.Research by a team at Johns Hopkins revealed that by combining minimally...

Read More...

Stroke belt 'associated with cognitive decline'

27 May 2011

The stroke belt in the US also has a higher incidence of cognitive decline than other parts of the country, indicating that the brain injury has shared risk factors with stroke.Research published in Annals...

Read More...